Corona vaccine development: First clinical studies

The development of vaccines against Covid-19 continues to grow rapidly. Worldwide, there are, according to the Association of Research-based pharmaceutical manufacturers (vfa) 115 vaccine projects for the protection against the Coronavirus.

“Although the pathogen prior to the start of the year was still virtually unknown, had to 1. February already reported six companies vaccine projects. On 9. In March there were 16 and now there are 115,” said vfa-speaker Rolf Hömke.

“Seven of them will be driven mainly in Germany, five are supported out of Germany.”

It’ll work on vaccines of different types, said Hömke. For some it is a case of inactivated vaccines, such as those used against Tetanus and Hepatitis-B.

In addition, research on vaccines containing Virus components, as well as live vaccinations. The latter vaccinations contain a harmless, so-called vector viruses.

In addition, genbasierte vaccines are, with genes from the Virus, in work. “The method is new, and there is as yet no approved vaccine of this type against any disease,” said Hömke.

Worldwide, ten of the 115 vaccine to be tested candidates already in clinical trials with volunteers. One of them takes place in Germany.

In June, the first data of the Tests should be available in around 200 healthy people between 18 and 55 years of age.

First, companies and research institutes have announced, according to the VfA already, their production capacity for a Covid-19 vaccine to expand.

Several of them want to produce the Association, according to their vaccines even during the trial, with volunteers already on a large scale.

You take the risk to have produced goods to dispose of if the study should be results of negative.

Deutsche Presse-Agentur (dpa)

*The post “Corona vaccine development: First clinical trials” is published by FitForFun. Contact with the executives here.